galantamine and physostigmine

galantamine has been researched along with physostigmine in 66 studies

Research

Studies (66)

TimeframeStudies, this research(%)All Research%
pre-199016 (24.24)18.7374
1990's11 (16.67)18.2507
2000's21 (31.82)29.6817
2010's13 (19.70)24.3611
2020's5 (7.58)2.80

Authors

AuthorsStudies
Bigg, DC; Briley, M; Calmel, F; Carilla, E; Vidaluc, JL1
Bigg, D; Briley, M; Calmel, F; Carilla, E; Chopin, P; Stenger, A; Vidaluc, JL1
Brossi, A; Greig, NH; Holloway, HW; Whittaker, NF; Yu, QS; Zhu, X1
Alley, GM; Brossi, A; Deschamps, JR; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, D; Yu, QS; Zhan, M1
Brossi, A; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, DA; Shafferman, A; Tweedie, D; Yu, QS1
Decker, M; Lehmann, J; Rommelspacher, H; Schott, Y1
Arnold, N; Brandt, W; Geissler, T; Kehlen, A; Porzel, A; Schlenzig, D; Wessjohann, L1
Bellman, K; Knegtel, RM; Settimo, L1
Ansari, FL; Hall, CD; Jabeen, F; Katritzky, AR; Oliferenko, AA; Oliferenko, PV; Pillai, GG1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Awang, K; Khaw, KY; Liew, SY; Litaudon, M; Murugaiyah, V; Wan Othman, WNN1
Darekar, MN; Gurjar, AS; Ooi, L; Yeong, KY1
Ji, J; Peng, Y; Rakesh, KP; Wang, S; Xu, M; Zhu, L1
Al Mamun, A; Cahlíková, L; Hulcová, D; Kobrlová, T; Kohelová, E; Korábečný, J; Kučera, T; Kuneš, J; Maříková, J; Nováková, L; Peřinová, R; Ritomská, A1
Curtis, MA; Lin, SX; Sperry, J1
Cahlíková, L; Carmen Catapano, M; Hulcová, D; Janoušek, J; Jenčo, J; Kohelová, E; Korábečný, J; Kučera, T; Kuneš, J; Maafi, N; Maříková, J; Mecava, M; Nováková, L; Pidaný, F; Prchal, L; Schmidt, M; Shammari, LA; Špulák, M1
Andricopulo, AD; Cenci, AR; de Oliveira, AS; Ferreira, LLG; Machado, V; Nunes, RJ; Sandjo, LP; Sens, L; Teixeira, KF; Tizziani, T; Yunes, RA1
Aleksandriĭskaia, IE; Brestkina, LM; Sofronov, GA; Tonkopiĭ, VD1
Cozanitis, DA1
Barz, H; Bickel, U; Cervos-Navarro, J; Fischer, JP; Gusztony, G; Kaden, B; Kewitz, H; Thomsen, T1
Dubovitskaia, SI; Khromova, ON; Prozorovskiĭ, VB; Vladeeva, NV1
Schmidt, J; Wolf, H1
Andreas, K; Lehmann, K; Walther, H1
Kumbier, E; Liebmann, H; Matthies, H1
Gladysheva, NI; Khromova, ON; Prozorovskiĭ, VB1
Prozorovskiĭ, VB1
Gumulka, W; Kostowski, W1
Chanley, JD; Durant, RC; Friess, SL; Mezzetti, T1
Il'iuchenok, RIu; Nesterenko, LN1
Kagei, K; Koshiro, A; Shirai, H; Uyeo, S; Yashiro, T1
Cozanitis, DA; Friedmann, T; Fürst, S1
Ducardus, R; Dworacek, B; Dzoljic, MR; Rupreht, J; Schmitz, PI1
Krivoĭ, II; Kuleshov, VI; Matiushkin, DP; Sanotskiĭ, VI; Shabunova, IA1
Abdel Ghani, EM; Cooper, JC; Gutbrod, O; Hermsen, B; Lobron, C; Reinhardt, S; Schrattenholz, A; Soskiç, V; Storch, A; Weber, KH1
Bahro, M; Berger, M; Gann, H; Hohagen, F; Lis, S; Riemann, D; Stadmüller, G1
Feng, J; Liu, JS; Tang, XC; Xu, H; Zhou, TX1
Albuquerque, EX; Alkondon, M; Lindstrom, J; Maelicke, A; Peng, X; Pereira, EF; Reinhardt, S; Whiting, P1
Johansson, M; Nordberg, A1
Albuquerque, EX; Maelicke, A; Pereira, EF; Reinhardt-Maelicke, S; Schrattenholz, A1
Camacho, F; Smith, CP; Vargas, HM; Winslow, JT1
Mielke, R1
Robert, P1
Houghton, PJ; Howes, MJ; Perry, NS1
Harmon, HJ; Legako, JA; White, BJ1
Butler, R; Prabhakaran, P; Warner, J1
PODLESNAIA, AI1
Caricati-Neto, A; D'angelo, LC; Garcia, AG; Hyppolito Jurkiewicz, N; Jurkiewicz, A; Reuter, H1
Arya, P; Butler, R; Warner, J2
Bermudez, I; Groot-Kormelink, PJ; Smulders, CJ; van Kleef, RG; Vijverberg, HP; Zwart, R1
Bottlaender, M; Coulon, C; Dollé, F; Ottaviani, M; Syrota, A; Valette, H1
Bertchume, A; Colvin, J; Csernansky, JG; Dong, H; Martin, M; Shah, R1
Castro, A; Martinez, A1
Butler, R; Warner, J; Wuntakal, B1
Collins, D; Easwaramoorthy, B; Leslie, FM; Mukherjee, J; Pichika, R; Potkin, SG1
Kircher, T; Leucht, S; Thienel, R; Voss, B1
Bajda, M; Malawska, B; Musiał, A1
Ehret, A; Feuerstein, TJ; Förster, S; Jackisch, R; Kammerer, M; Rothmaier, AK; Zentner, J1
Ilavazhagan, G; Maiti, P; Muthuraju, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P2
Auber, A; Chiamulera, C; Giarola, A1
Ilavazhagan, G; Maiti, P; Muthuraju, S; Pati, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P1
Cohen, JB; Hamouda, AK; Kimm, T1
Cesario, A; Del Bufalo, A; Fini, M; Frustaci, A; Russo, P1
Barnhart, TE; Christian, BT; Farhoud, M; Higgins, AT; Hillmer, AT; Lao, PJ; Mukherjee, J; Wooten, DW1
Fitzgerald, PJ; Ghimire, A; Hale, PJ; Watson, BO1

Reviews

14 review(s) available for galantamine and physostigmine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
    European journal of medicinal chemistry, 2019, Oct-15, Volume: 180

    Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship; Triazoles

2019
Pyridine alkaloids with activity in the central nervous system.
    Bioorganic & medicinal chemistry, 2020, 12-15, Volume: 28, Issue:24

    Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic

2020
Pharmacokinetic studies of cholinesterase inhibitors.
    Acta neurologica Scandinavica. Supplementum, 1993, Volume: 149

    Topics: Adult; Aged; Alzheimer Disease; Female; Galantamine; Humans; Male; Middle Aged; Physostigmine; Tacrine

1993
Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.
    Current medical research and opinion, 2002, Volume: 18, Issue:3

    Topics: Acetylcholine; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Disease Progression; Donepezil; Galantamine; Humans; Indans; Neuroprotective Agents; Phenylcarbamates; Physostigmine; Piperidines; Rivastigmine; Tacrine; Time Factors; Treatment Outcome

2002
Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders.
    Phytotherapy research : PTR, 2003, Volume: 17, Issue:1

    Topics: Alkaloids; Alzheimer Disease; Estrogens, Non-Steroidal; Galantamine; Humans; Isoflavones; Physostigmine; Phytoestrogens; Phytotherapy; Plant Extracts; Plant Preparations; Plants, Medicinal; Sesquiterpenes

2003
Dementia.
    Clinical evidence, 2003, Issue:9

    Topics: Alzheimer Disease; Anticonvulsants; Antipsychotic Agents; Carbamates; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Nootropic Agents; Phenylcarbamates; Phosphatidylcholines; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine; Vitamin E

2003
Dementia.
    Clinical evidence, 2004, Issue:11

    Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E

2004
Dementia.
    Clinical evidence, 2004, Issue:12

    Topics: Alzheimer Disease; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine

2004
Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
    Expert opinion on investigational drugs, 2006, Volume: 15, Issue:1

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Galantamine; Humans; Physostigmine; Protein Conformation

2006
Dementia.
    Clinical evidence, 2005, Issue:14

    Topics: Alzheimer Disease; Benzodiazepines; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Selegiline; Tacrine

2005
[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
    Der Nervenarzt, 2008, Volume: 79, Issue:1

    Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Physostigmine; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

2008
Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.
    Current medicinal chemistry, 2007, Volume: 14, Issue:25

    Topics: Alkaloids; Alzheimer Disease; Binding Sites; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Indole Alkaloids; Isoquinolines; Phenylcarbamates; Physostigmine; Piperidines; Propidium; Rivastigmine; Steroids; Tacrine

2007
Multitarget drugs of plants origin acting on Alzheimer's disease.
    Current medicinal chemistry, 2013, Volume: 20, Issue:13

    Topics: Alkaloids; Alzheimer Disease; Animals; Biological Products; Cholinesterase Inhibitors; Crocus; Drug Discovery; Galantamine; Galanthus; Ginkgo biloba; Humans; Huperzia; Neuroprotective Agents; Physostigmine; Plant Extracts; Plants; Salvia; Sesquiterpenes

2013

Trials

1 trial(s) available for galantamine and physostigmine

ArticleYear
Cholinergic neurotransmission, REM sleep and depression.
    Journal of psychosomatic research, 1994, Volume: 38 Suppl 1

    Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Mental Disorders; Middle Aged; Parasympathomimetics; Physostigmine; Polysomnography; Reaction Time; Receptors, Muscarinic; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Succinimides; Synaptic Transmission; Tacrine

1994

Other Studies

51 other study(ies) available for galantamine and physostigmine

ArticleYear
Flexible 1-[(2-aminoethoxy)alkyl]-3-ar(o)yl(thio)ureas as novel acetylcholinesterase inhibitors. Synthesis and biochemical evaluation.
    Journal of medicinal chemistry, 1995, Jul-21, Volume: 38, Issue:15

    Topics: Animals; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Molecular Conformation; Rats; Structure-Activity Relationship; Thiourea

1995
Novel [2-(4-piperidinyl)ethyl](thio)ureas: synthesis and antiacetylcholinesterase activity.
    Journal of medicinal chemistry, 1994, Mar-04, Volume: 37, Issue:5

    Topics: Acetylcholinesterase; Amnesia; Animals; Avoidance Learning; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Hydrogen Bonding; Mice; Molecular Conformation; Molecular Structure; Piperidines; Rats; Scopolamine; Structure-Activity Relationship; Thiourea

1994
Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.
    Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17

    Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship

2002
Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
    Journal of medicinal chemistry, 2005, Feb-24, Volume: 48, Issue:4

    Topics: Acetylcholinesterase; Amyloid beta-Protein Precursor; Benzofurans; Butyrylcholinesterase; Carbamates; Cell Line; Cell Survival; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Neurons; Oxepins; Structure-Activity Relationship

2005
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.
    Journal of medicinal chemistry, 2006, Apr-06, Volume: 49, Issue:7

    Topics: Acetophenones; Acetylcholinesterase; Animals; Benzofurans; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Heterocyclic Compounds, 3-Ring; Humans; Models, Molecular; Oxepins; Stereoisomerism; Structure-Activity Relationship; Torpedo

2006
6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.
    Bioorganic & medicinal chemistry letters, 2006, Nov-15, Volume: 16, Issue:22

    Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Carbolines; Cholinesterase Inhibitors; Galantamine; Humans; Inhibitory Concentration 50; Phenylcarbamates; Physostigmine; Rivastigmine; Serotonin

2006
Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Acetylcholinesterase; Agaricales; Animals; Cattle; Cholinesterase Inhibitors; Erythrocytes; Fruiting Bodies, Fungal; Heterocyclic Compounds, 4 or More Rings; Molecular Structure; Stereoisomerism; Structure-Activity Relationship

2010
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis.
    European journal of medicinal chemistry, 2014, Jun-10, Volume: 80

    Topics: alpha-Glucosidases; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Glycoside Hydrolase Inhibitors; Inhibitory Concentration 50; Quantitative Structure-Activity Relationship

2014
Cholinesterase inhibitory activity of isoquinoline alkaloids from three Cryptocarya species (Lauraceae).
    Bioorganic & medicinal chemistry, 2016, 09-15, Volume: 24, Issue:18

    Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cryptocarya; Humans; Inhibitory Concentration 50; Isoquinolines; Kinetics; Molecular Docking Simulation; Plant Extracts; Spectrum Analysis

2016
In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
    Bioorganic & medicinal chemistry, 2018, 05-01, Volume: 26, Issue:8

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophorus; Female; Horses; Imidazoles; Male; Maze Learning; Memory Disorders; Mice; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship

2018
Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase.
    Journal of natural products, 2020, 05-22, Volume: 83, Issue:5

    Topics: Amaryllidaceae; Amaryllidaceae Alkaloids; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Esters; Humans; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Substrate Specificity

2020
Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study.
    Bioorganic & medicinal chemistry letters, 2021, 11-01, Volume: 51

    Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Isoquinolines; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship

2021
Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies.
    RSC medicinal chemistry, 2022, Dec-14, Volume: 13, Issue:12

    Topics:

2022
[Mechanism of the effect of diazepam on acetylcholine concentration in mouse brain].
    Biulleten' eksperimental'noi biologii i meditsiny, 1978, Volume: 86, Issue:7

    Topics: Acetylcholine; Acetylcholinesterase; Animals; Brain; Brain Chemistry; Cholinesterase Inhibitors; Diazepam; Dose-Response Relationship, Drug; Galantamine; Lethal Dose 50; Male; Mice; Nitrobenzenes; Organophosphorus Compounds; Paraoxon; Physostigmine

1978
[Galanthamine hydrobromide : a substitute for eserine sulphate (physostigmine) in the treatment of the cerebral effects of anti-cholinergic substances].
    La Nouvelle presse medicale, 1978, Volume: 7, Issue:45

    Topics: Animals; Brain Diseases; Galantamine; Humans; Parasympatholytics; Physostigmine

1978
Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine.
    European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, 1991, Volume: 29, Issue:8

    Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Erythrocytes; Female; Galantamine; Hippocampus; Humans; Male; Mice; Middle Aged; Physostigmine; Tacrine

1991
[The antimyorelaxant effect of cholinopotentiating drugs].
    Biulleten' eksperimental'noi biologii i meditsiny, 1970, Volume: 69, Issue:6

    Topics: Ambenonium Chloride; Animals; Anura; Cholinesterase Inhibitors; Colorimetry; Galantamine; Male; Miotics; Neostigmine; Neuromuscular Nondepolarizing Agents; Organophosphonates; Phosphates; Physostigmine; Rats; Tubocurarine

1970
[Influence of atropine and cholinesterase inhibitors on brain potentials caused by dental pulp stimulation].
    Acta biologica et medica Germanica, 1972, Volume: 29, Issue:4

    Topics: Animals; Atropine; Brain; Cholinesterase Inhibitors; Dental Pulp; Electric Stimulation; Evoked Potentials; Female; Galantamine; Isoflurophate; Male; Paraoxon; Physostigmine; Rabbits

1972
[Dose-action relationship in cholinergically induced theta rhythm in the rat hippocampus].
    Acta biologica et medica Germanica, 1971, Volume: 27, Issue:4

    Topics: Animals; Bromides; Electrodes, Implanted; Electroencephalography; Evoked Potentials; Galantamine; Hippocampus; Nicotinic Acids; Parasympathomimetics; Physostigmine; Rats; Rats, Inbred Strains; Salicylates; Tremorine

1971
[Effect of phenelzine on the toxicity of cholinergic drugs modified by reserpine].
    Acta biologica et medica Germanica, 1971, Volume: 26, Issue:3

    Topics: Animals; Cholinesterase Inhibitors; Drug Interactions; Female; Galantamine; Isoflurophate; Lethal Dose 50; Male; Mice; Monoamine Oxidase Inhibitors; Neostigmine; Paraoxon; Parasympathomimetics; Phenelzine; Physostigmine; Reserpine; Toxicology

1971
[Reactivity of isolated rat intestine to choline potentiating compounds].
    Farmakologiia i toksikologiia, 1971, Volume: 34, Issue:1

    Topics: Acetylcholine; Ambenonium Chloride; Animals; Cholinesterase Inhibitors; Depression, Chemical; Galantamine; Ileum; In Vitro Techniques; Male; Miotics; Muscle Contraction; Muscle, Smooth; Neostigmine; Nicotine; Nicotinic Acids; Organophosphonates; Parasympathomimetics; Phosphates; Physostigmine; Rats; Stimulation, Chemical

1971
[Alteration of the primary response of the somatosensory area of the cortex on exposure to choline potentiating substances].
    Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova, 1967, Volume: 53, Issue:8

    Topics: Animals; Cats; Cerebral Cortex; Cholinesterase Inhibitors; Electrophysiology; Epinephrine; Evoked Potentials; Galantamine; Neostigmine; Neurons; Parasympathetic Nervous System; Parasympatholytics; Physostigmine; Radial Nerve

1967
Note on the ganglionic and central actions of galantamine.
    International journal of neuropharmacology, 1968, Volume: 7, Issue:1

    Topics: Acetylcholine; Animals; Atropine; Benactyzine; Cats; Cerebral Cortex; Electroencephalography; Evoked Potentials; Galantamine; Ganglia, Autonomic; Hexamethonium Compounds; Hippocampus; Phenobarbital; Physostigmine; Stimulation, Chemical; Tubocurarine

1968
Some structural requirements underlying holothurin A interactions with synaptic chemoreceptors.
    Biochemical pharmacology, 1965, Volume: 14, Issue:8

    Topics: Animals; Chemical Phenomena; Chemistry, Physical; Diaphragm; Galantamine; In Vitro Techniques; Neostigmine; Neurochemistry; Neuromuscular Junction; Phrenic Nerve; Physostigmine; Rats; Sensory Receptor Cells; Toxins, Biological

1965
[Acetylcholinesterase and the bioelectrical activity of the brain under the action of eserine and galanthamine in animals with premesencephalic section of the brain].
    Biulleten' eksperimental'noi biologii i meditsiny, 1965, Volume: 60, Issue:10

    Topics: Acetylcholinesterase; Animals; Brain; Cats; Electroencephalography; Galantamine; Mesencephalon; Physostigmine; Reticular Formation

1965
Galanthamine chemistry. VII. Synthesis of analogues of galanthamine.
    Chemical & pharmaceutical bulletin, 1966, Volume: 14, Issue:9

    Topics: Animals; Chemistry, Organic; Cholinesterase Inhibitors; Galantamine; Neostigmine; Organic Chemistry Phenomena; Physostigmine

1966
Study of the analgesic effects of galanthamine, a cholinesterase inhibitor.
    Archives internationales de pharmacodynamie et de therapie, 1983, Volume: 266, Issue:2

    Topics: Analgesics; Anesthesia; Animals; Barbiturates; Cats; Drug Synergism; Female; Galantamine; Guinea Pigs; In Vitro Techniques; Male; Mice; Morphine; Muscle Contraction; Muscle, Smooth; Physostigmine; Rats; Reaction Time

1983
The involvement of the central cholinergic and endorphinergic systems in the nitrous oxide withdrawal syndrome in mice.
    Anesthesiology, 1983, Volume: 58, Issue:6

    Topics: Animals; Brain; Endorphins; Galantamine; Humans; Male; Mice; Naloxone; Nitrous Oxide; Parasympathetic Nervous System; Physostigmine; Seizures; Substance Withdrawal Syndrome

1983
[Effect of cholinesterase inhibitors on the electrical excitability of the membrane of frog muscle fiber].
    Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova, 1982, Volume: 68, Issue:9

    Topics: Action Potentials; Animals; Anura; Armin; Cholinesterase Inhibitors; Drug Interactions; Electric Stimulation; Galantamine; In Vitro Techniques; Neuromuscular Junction; Physostigmine; Synaptic Membranes

1982
Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells.
    European journal of pharmacology, 1995, Aug-15, Volume: 290, Issue:3

    Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Codeine; Galantamine; In Situ Hybridization; Ion Channels; Ligands; Nicotinic Agonists; Nicotinic Antagonists; Patch-Clamp Techniques; PC12 Cells; Physostigmine; Rats; Rats, Wistar; Receptors, Nicotinic; Structure-Activity Relationship

1995
Effect of cholinesterase inhibition in vitro by huperzine analogs.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1994, Volume: 15, Issue:2

    Topics: Acetylcholinesterase; Alkaloids; Animals; Cholinesterase Inhibitors; Erythrocyte Membrane; Galantamine; Physostigmine; Rats; Sesquiterpenes; Structure-Activity Relationship

1994
Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Bacterial Toxins; Binding Sites; Cells, Cultured; Chickens; Cyanobacteria Toxins; Dexamethasone; Dose-Response Relationship, Drug; Fibroblasts; Galantamine; Kinetics; Marine Toxins; Membrane Potentials; Microcystins; Molecular Probes; Neurons; Nicotine; Physostigmine; Receptors, Nicotinic; Recombinant Proteins; Tropanes

1994
Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:3

    Topics: Amino Acid Sequence; Animals; Antibodies; Binding Sites; Cells, Cultured; Evoked Potentials; Female; Fibroblasts; Galantamine; Hippocampus; Immunohistochemistry; Kinetics; Membranes; Molecular Sequence Data; Neurons; Physostigmine; Pregnancy; Quaternary Ammonium Compounds; Rats; Receptors, Nicotinic

1993
Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat.
    Psychopharmacology, 1996, Volume: 124, Issue:4

    Topics: Adrenergic alpha-Antagonists; Animals; Avoidance Learning; Benzazepines; Cholinesterase Inhibitors; Drug Synergism; Galantamine; Idazoxan; Male; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine; Yohimbine

1996
[Neuroprotective therapy of Alzheimer's disease?].
    Deutsche medizinische Wochenschrift (1946), 1996, Nov-29, Volume: 121, Issue:48

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Galantamine; Humans; Neuroprotective Agents; Physostigmine; Piracetam; Tacrine

1996
Extended lifetime of reagentless detector for multiple inhibitors of acetylcholinesterase.
    Biosensors & bioelectronics, 2003, Volume: 18, Issue:5-6

    Topics: Acetylcholinesterase; Binding, Competitive; Biosensing Techniques; Cholinesterase Inhibitors; Diazinon; Enzymes, Immobilized; Equipment Design; Equipment Failure Analysis; Equipment Reuse; Galantamine; Indicators and Reagents; Octoxynol; Physostigmine; Porphyrins; Quality Control; Reproducibility of Results; Scopolamine; Sensitivity and Specificity; Spectrum Analysis; Tetracaine

2003
[PARAMYON-INDUCED CONTRACTURE OF THE DORSAL MUSCLE OF A LEECH UNDER THE EFFECT OF ANTICHOLINESTERASE AGENTS].
    Biulleten' eksperimental'noi biologii i meditsiny, 1963, Volume: 55

    Topics: Acetylcholine; Animals; Cholinesterase Inhibitors; Contracture; Galantamine; Leeches; Leeching; Muscle Relaxants, Central; Neostigmine; Pharmacology; Physostigmine; Research

1963
Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
    European journal of pharmacology, 2004, Oct-25, Volume: 503, Issue:1-3

    Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Donepezil; Drug Synergism; Electric Stimulation; Galantamine; In Vitro Techniques; Indans; Male; Muscle Contraction; Muscle, Smooth; Nicotine; Nicotinic Agonists; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Receptors, Purinergic; Rivastigmine; Stimulation, Chemical; Synaptic Transmission; Tacrine; Vas Deferens

2004
Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
    European journal of pharmacology, 2005, Feb-21, Volume: 509, Issue:2-3

    Topics: Acetylcholine; Alkaloids; Animals; Atropine; Azocines; Binding, Competitive; Cholinergic Agents; Cholinesterase Inhibitors; Dichlorvos; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Membrane Potentials; Models, Biological; Nicotine; Oocytes; Phenylcarbamates; Physostigmine; Plasmids; Quinolizines; Receptors, Nicotinic; Rivastigmine; Scopolamine; Tacrine; Xenopus laevis

2005
Acute effects of physostigmine and galantamine on the binding of [18F]fluoro-A-85380: a PET study in monkeys.
    Synapse (New York, N.Y.), 2005, Jun-15, Volume: 56, Issue:4

    Topics: Analysis of Variance; Animals; Azetidines; Binding, Competitive; Brain; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Galantamine; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Papio papio; Physostigmine; Positron-Emission Tomography; Reproducibility of Results; Time Factors; Tissue Distribution

2005
Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:12

    Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Cognition; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Galantamine; Indans; Learning; Male; Maze Learning; Mice; Mice, Inbred C57BL; Physostigmine; Piperidines; Receptors, Nicotinic

2005
Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
    Synapse (New York, N.Y.), 2007, Volume: 61, Issue:1

    Topics: Acetylcholine; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Fluorine Radioisotopes; Galantamine; Male; Physostigmine; Positron-Emission Tomography; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic

2007
Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex.
    Journal of Alzheimer's disease : JAD, 2009, Volume: 16, Issue:3

    Topics: Acetylcholine; Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Galantamine; Humans; In Vitro Techniques; Indans; Middle Aged; Neocortex; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Rivastigmine; Tacrine; Young Adult

2009
Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia.
    Behavioural brain research, 2009, Oct-12, Volume: 203, Issue:1

    Topics: Acetylcholine; Acetylcholinesterase; Air Pressure; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Galantamine; Hippocampus; Hypoxia; Male; Maze Learning; Memory; Neurons; Neuroprotective Agents; Physostigmine; Random Allocation; Rats; Rats, Sprague-Dawley

2009
Cholinesterase inhibitors ameliorate spatial learning deficits in rats following hypobaric hypoxia.
    Experimental brain research, 2010, Volume: 203, Issue:3

    Topics: Acetylcholine; Acetylcholinesterase; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Cerebral Cortex; Cholinesterase Inhibitors; Galantamine; Hypoxia; Learning Disabilities; Maze Learning; Nootropic Agents; Physostigmine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Space Perception

2010
Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats.
    Behavioural pharmacology, 2011, Volume: 22, Issue:1

    Topics: Animals; Cholinesterase Inhibitors; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Galantamine; Generalization, Stimulus; Male; Nicotine; Nicotinic Agonists; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine

2011
Possible role of cholinesterase inhibitors on memory consolidation following hypobaric hypoxia of rats.
    The International journal of neuroscience, 2011, Volume: 121, Issue:5

    Topics: Acetylcholine; Air Pressure; Altitude Sickness; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Galantamine; Hypoxia, Brain; Male; Maze Learning; Memory; Memory Disorders; Physostigmine; Rats; Rats, Sprague-Dawley; Time Factors; Treatment Outcome

2011
Physostigmine and galanthamine bind in the presence of agonist at the canonical and noncanonical subunit interfaces of a nicotinic acetylcholine receptor.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Jan-09, Volume: 33, Issue:2

    Topics: Algorithms; Animals; Binding Sites; Cholinergic Agonists; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Galantamine; Hydrolysis; In Vitro Techniques; Ion Channels; Models, Molecular; Peptide Hydrolases; Photochemistry; Physostigmine; Polymerase Chain Reaction; Radioligand Assay; Receptors, GABA-A; Receptors, Nicotinic; Torpedo

2013
PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor binding.
    Synapse (New York, N.Y.), 2013, Volume: 67, Issue:12

    Topics: Animals; Brain; Cholinesterase Inhibitors; Female; Galantamine; Physostigmine; Positron-Emission Tomography; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic

2013
Multiple cholinesterase inhibitors have antidepressant-like properties in the mouse forced swim test.
    Behavioural brain research, 2021, 07-09, Volume: 409

    Topics: Animals; Antidepressive Agents; Association Learning; Behavior, Animal; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Repositioning; Galantamine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Physostigmine; Rivastigmine; Swimming

2021